150 patients were excluded from further analysis due to missing surgery, missing IDH mutation, missing follow-up, or diagnosis inconsistent with grade 2 or 3 astrocytoma or oligodendroglioma (Fig. 1). This evidence concerns the gene IDH2 and oligodendroglioma.